Then David, who leads the Factor XI clinical program at Regeneron, will present preclinical data as well as clinical data from the ROXI-VTE-I and II studies in venous thromboembolism prevention post ...

Clinical Outcomes -- Twelve-month study data for the Catamaran implant showed VAS scores decreased from 78.8 to 23, and ODI ...

Hutchmed unveiled new details on its expanding oncology pipeline and research strategy, including the launch of its ...

Rounding out Lakeville’s slate of major commercial construction projects is the Lakeville 35 Logistics Center, a ...

Q3 2025 Earnings Call Transcript November 13, 2025 DarioHealth Corp. misses on earnings expectations. Reported EPS is $ EPS, ...

The pipeline giant’s plan to expand the congested South West Pipeline reflects its wider grid expansion strategy to head off the need for LNG imports.

Q3 2025 Earnings Call Transcript November 3, 2025 BioNTech SE misses on earnings expectations. Reported EPS is $-0.14 EPS, ...

Harvard Business School invited the actress and entrepreneur to give a talk on entrepreneurship and female empowerment.

Detailed price information for Co-Diagnostics Inc (CODX-Q) from The Globe and Mail including charting and trades.

(4168, hereinafter referred to as GNX), today announced that the last patient has received the final dose in its Phase 3 clinical study of SPD8, a biosimilar to denosumab for the treatment of ...

Year, Marking Second Consecutive Quarter of Double-Digit GrowthBuilding Momentum for 2026 Through Continued Organic ...

PRNewswire/ - i-80 GOLD CORP. (TSX: IAU) (NYSE American: IAUX) ("i-80 Gold" or the "Company") reports its operating and financial results for the three and nine months ended September 30, 2025, ...